|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1446 Duke Street |
Address2 |
|
City | Alexandria |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 28481-12
|
||||||||
|
6. House ID# 316440000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jennifer Popik |
Date | 1/20/2021 10:25:40 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Contacts in support of retaining all current pro-life appropriations riders and funding levels in FY21 appropriations.
Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CON
16. Specific lobbying issues
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by Congress in March 1972, with a ratification deadline that expired in March 1979. This includes opposition to H.J. Res. 79 and S.J. Res. 6 (purporting by unconstitutional mechanisms to nullify the ratification deadline contained in the joint resolution submitted to the states in 1972), and to any actions by which any organ of the Executive Branch would purport to recognize as viable the long-expired 1972 proposal. Opposition extends also to current text of H.J. Res 35 and S. J. Res. 15 (proposing re-submission of ERA language to the states, this time without a ratification deadline).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Justice - Dept of (DOJ), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age.
Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020. Contacts in support of administrative action enforcing existing EMTALA provisions regarding infact treatment and the Born-Alive Infant protection act to the fullest extent possible by law.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion.
Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion.
Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Consultations regarding letters of inquiry regarding whether abortion providers have violated various provisions of law regarding human fetal tissue sale or the partial birth abortion ban law.
Contacts regarding a resolution condemning unwanted, unnecessary medical procedures on individuals without their full, informed consent (H. Res. 1154). No position taken.
Contacts in support of legislation (not introduced) banning unwanted medical procedures.
Contacts regarding the Pregnant Workers Fairness Act (H.R. 2694). No position taken.
Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced).
Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter.
Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans."
Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law.
Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions.
Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590).
Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to enforce REMS during Covid-19 pandemic.
Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome.
Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order.
Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent.
Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises.
Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos.
Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion.
Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion.
Contacts in opposition to the HEROES Act 2.0, which contains numerous provisions that permit funds to flow to the abortion industry as well as potentially funneling millions of dollars into programs without Hyde protections.
Contacts in support of H.R. 6742, the Protecting Life in Crisis Act which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance.
Contacts in opposition to Medicare for All legislation (H.R. 1384 and S. 1129) because they mandate government coverage of abortions and are likely to require hospitals and doctors to perform abortion procedures.
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal.
Contacts regarding strengthening guidance to providers against steering patients away from treatment.
Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market.
Contacts in opposition to H.R. 1425 which includes: 1) Permanent tax credit increases to the Patient Protection and Affordable Care Act; 2) A new federal reinsurance program run by states without Hyde-like protections; and 3) Prescription drug price controls that will lead to the rationing of treatment; letter to the House dated June 29, 2020.
Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of eliminating "advance care planning services" from the CMS list of services in the Medicare Physician Fee Schedule payment rule.
Contacts regarding administrative changes to Medicare part D requiring step therapy and drug price capping based on a look-back period as it would relate to the delay or denial of life-saving medication.
Contacts in opposition to administrative changes to International Price Indexing as it would base drug prices off of international prices that utilize the quality-adjusted-life year which is used to deny treatment to patients with ongoing medical needs and persons with disabilities.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), Natl Council on Disability
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2021 Foreign Operations appropriations vehicle.
Contacts in support of enforcement, and expansion of the Protecting Life in Global Health Assistance policy.
Contacts in support of retaining pro-life policies in the Organization of American States.
Contacts regarding the Women's Global Empowerment, Development and Prosperity Act of 2020 (S.3301) to ensure that the Helms and Siljander amendments apply to any funds.
Contacts regarding abortion-related implications of H.R. 6117, the Women's Global Development and Prosperity Act of 2020. Contacts in opposition to codifying the Global Women's Initiative as a permanent office.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Contacts in support of nomination and/or confirmation of practitioners of judicial restraint to current and future vacancies on the federal courts, including the confirmation of Judge Amy Coney Barrett as Associate Justice of the United States Supreme Court.
Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Executive Office of the President (EOP), U.S. HOUSE OF REPRESENTATIVES, Office of Personnel Management (OPM)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
Contacts in opposition to the Equality Act (H.R. 5) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions.
Contacts in support of enforcement of the Americans with Disabilities Act as it would apply to states who permit legal assisted suicide in a discriminatory manner.
Contacts in support of guidance from HHS and/or legislative language regarding discriminatory state and hospitals policies that would ration treatment based on age, degree of disability, and quality of life during Covid-19 pandemic.
Contacts in support of administrative guidance related to the discriminatory use of the quality-adjusted life-year to deny treatment.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Natl Council on Disability
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2019 (H.R. 2266/ S.1150) to extend the existing child tax credit to apply to the unborn child prior to birth and permit the credit to be claimed in the childs first year of life.
Contacts in support of the No Abortion Bonds Act to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers.
Contacts regarding IRS guidance and preferential tax treatment of costs associated with elective abortion as well as of plans that cover elective abortion.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |